{
    "pmcid": "7500280",
    "qa_pairs": {
        "What computational method was used to quantify the binding interactions between the SARS-CoV-2 spike protein RBD and the human ACE2 receptor?": [
            "Rosetta energy function",
            "Molecular dynamics simulations",
            "Quantum mechanical calculations",
            "Docking simulations"
        ],
        "What is one potential application of the study's findings on the binding dynamics of the SARS-CoV-2 spike protein?": [
            "Designing nanobody binders",
            "Developing vaccines",
            "Creating diagnostic tests",
            "Engineering viral vectors"
        ],
        "What is the Rosetta binding score for the SARS-CoV-2 spike protein's interaction with hACE2, indicating its binding affinity?": [
            "\u221248.312 \u00b1 3.4 kcal/mol",
            "\u221235.210 \u00b1 2.5 kcal/mol",
            "\u221260.123 \u00b1 4.0 kcal/mol",
            "\u221225.678 \u00b1 3.0 kcal/mol"
        ],
        "What percentage of the interface residues in the SARS-CoV-2 RBD were identified as crucial for binding with hACE2 through computational alanine scanning?": [
            "Approximately 90%",
            "Approximately 70%",
            "Approximately 50%",
            "Approximately 30%"
        ],
        "Which species' ACE2 receptor was found to have the strongest binding affinity with the SARS-CoV-2 spike protein according to the comparative analysis?": [
            "Bat",
            "Human",
            "Feline",
            "Canine"
        ]
    }
}